BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells.

MLA

Campbell, Amy E., et al. “BET Bromodomain Inhibitors and Agonists of the Beta-2 Adrenergic Receptor Identified in Screens for Compounds That Inhibit DUX4 Expression in FSHD Muscle Cells.” Skeletal Muscle, vol. 7, Sept. 2017, pp. 1–18. EBSCOhost, https://doi.org/10.1186/s13395-017-0134-x.

APA

Campbell, A. E., Oliva, J., Yates, M. P., Jun Wen Zhong, Shadle, S. C., Snider, L., Singh, N., Shannon Tai, Yosuke Hiramuki, Tawil, R., van der Maarel, S. M., Tapscott, S. J., & Sverdrup, F. M. (2017). BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells. Skeletal Muscle, 7, 1–18. https://doi.org/10.1186/s13395-017-0134-x

Chicago

Campbell, Amy E., Jonathan Oliva, Matthew P. Yates, Jun Wen Zhong, Sean C. Shadle, Lauren Snider, Nikita Singh, et al. 2017. “BET Bromodomain Inhibitors and Agonists of the Beta-2 Adrenergic Receptor Identified in Screens for Compounds That Inhibit DUX4 Expression in FSHD Muscle Cells.” Skeletal Muscle 7 (September): 1–18. doi:10.1186/s13395-017-0134-x.